Practical recommendations for the use of PARP inhibitors in the treatment of ovarian cancer
{{output}}
Background: There is no doubt that PARP inhibitors (PARPi) have significantly improved the prognosis of patients with advanced-stage ovarian cancer. In the history of treatment for this disease, their impact is second only to the... ...
